A549 cells infected with SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr8_-_141645645 Show fit | 0.87 |
ENST00000519980.1
ENST00000220592.5 |
argonaute RISC catalytic component 2 |
|
chr5_+_156887027 Show fit | 0.76 |
ENST00000435489.2
ENST00000311946.7 |
NIPA-like domain containing 4 |
|
chr22_-_39548627 Show fit | 0.75 |
ENST00000216133.5
|
chromobox homolog 7 |
|
chr7_-_131241361 Show fit | 0.74 |
ENST00000378555.3
ENST00000322985.9 ENST00000541194.1 ENST00000537928.1 |
podocalyxin-like |
|
chr6_-_31830655 Show fit | 0.73 |
ENST00000375631.4
|
sialidase 1 (lysosomal sialidase) |
|
chr19_+_45596218 Show fit | 0.70 |
ENST00000421905.1
ENST00000221462.4 |
protein phosphatase 1, regulatory subunit 37 |
|
chr15_-_90358048 Show fit | 0.69 |
ENST00000300060.6
ENST00000560137.1 |
alanyl (membrane) aminopeptidase |
|
chrX_-_103401649 Show fit | 0.69 |
ENST00000357421.4
|
solute carrier family 25, member 53 |
|
chr15_-_75135453 Show fit | 0.69 |
ENST00000569437.1
ENST00000440863.2 |
unc-51 like kinase 3 |
|
chr2_+_220042933 Show fit | 0.68 |
ENST00000430297.2
|
family with sequence similarity 134, member A |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 1.3 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.1 | 1.0 | GO:0090625 | mRNA cleavage involved in gene silencing by siRNA(GO:0090625) |
0.2 | 0.7 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.1 | 0.7 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.0 | 0.7 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.6 | GO:0042351 | 'de novo' GDP-L-fucose biosynthetic process(GO:0042351) |
0.1 | 0.6 | GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
0.0 | 0.6 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.0 | 0.6 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.0 | 0.6 | GO:0043306 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.0 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.8 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.1 | 0.7 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 0.7 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.0 | 0.7 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.1 | 0.6 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.1 | 0.6 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.1 | 0.6 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.0 | 0.6 | GO:0016600 | flotillin complex(GO:0016600) |
0.0 | 0.6 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.9 | GO:0098808 | mRNA cap binding(GO:0098808) |
0.0 | 0.9 | GO:0030371 | translation repressor activity(GO:0030371) |
0.0 | 0.8 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.0 | 0.8 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.1 | 0.7 | GO:0052794 | exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.0 | 0.7 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 0.7 | GO:0038191 | neuropilin binding(GO:0038191) |
0.2 | 0.6 | GO:0042356 | GDP-4-dehydro-D-rhamnose reductase activity(GO:0042356) GDP-L-fucose synthase activity(GO:0050577) |
0.1 | 0.6 | GO:0034046 | poly(G) binding(GO:0034046) |
0.0 | 0.6 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 1.4 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.0 | 1.0 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 1.0 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 0.7 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 0.5 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 0.5 | ST STAT3 PATHWAY | STAT3 Pathway |
0.0 | 0.5 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 0.9 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.0 | 0.8 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 0.7 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.0 | 0.7 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.7 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 0.6 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 0.5 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.5 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.0 | 0.5 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.0 | 0.5 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |